Online from: 1988
Subject Area: Health Care Management/Healthcare
Options: To add Favourites and Table of Contents Alerts please take a Emerald profile
|Title:||Quality management benchmarking: FDA compliance in pharmaceutical industry|
|Author(s):||Roland Jochem, (Institute for Industrial Science and Process Management, University Kassel, Kassel, Germany), Katja Landgraf, (Institute for Industrial Science and Process Management, University Kassel, Kassel, Germany)|
|Citation:||Roland Jochem, Katja Landgraf, (2010) "Quality management benchmarking: FDA compliance in pharmaceutical industry", International Journal of Health Care Quality Assurance, Vol. 23 Iss: 8, pp.690 - 698|
|Keywords:||Benchmarking, Germany, Pharmaceuticals industry, Process management, Quality management|
|Article type:||Case study|
|DOI:||10.1108/09526861011081813 (Permanent URL)|
|Publisher:||Emerald Group Publishing Limited|
|Acknowledgements:||This paper was guest edited for IJHCQA by Mosad Zineldin, Professor in Strategic Relationship Management, Linnaeus University, Sweden.|
Purpose – By analyzing and comparing industry and business best practice, processes can be optimized and become more successful mainly because efficiency and competitiveness increase. This paper aims to focus on some examples.
Design/methodology/approach – Case studies are used to show knowledge exchange in the pharmaceutical industry. Best practice solutions were identified in two companies using a benchmarking method and five-stage model.
Findings – Despite large administrations, there is much potential regarding business process organization. This project makes it possible for participants to fully understand their business processes. The benchmarking method gives an opportunity to critically analyze value chains (a string of companies or players working together to satisfy market demands for a special product).
Practical implications – Knowledge exchange is interesting for companies that like to be global players. Benchmarking supports information exchange and improves competitive ability between different enterprises. Findings suggest that the five-stage model improves efficiency and effectiveness. Furthermore, the model increases the chances for reaching targets. The method gives security to partners that did not have benchmarking experience.
Originality/value – The study identifies new quality management procedures. Process management and especially benchmarking is shown to support pharmaceutical industry improvements.
To purchase this item please login or register.
Complete and print this form to request this document from your librarian